12:00 AM
 | 
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zaltrap ziv-aflibercept regulatory update

EMA's CHMP issued a positive opinion recommending approval of Sanofi's Zaltrap ziv-aflibercept in combination with FOLFIRI chemotherapy to treat metastatic colorectal cancer (mCRC) that...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >